Trial NCT00086840

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2012-02598
Secondary IDs: CDR0000371619 MDA-2003-0886 N01CM17003

Last trial update was posted on 2013-01-24

MeSH Interventions

MTOR Inhibitors Sirolimus Temsirolimus

MeSH Conditions

Hodgkin Disease Leukemia Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Lymphoid Lymphoma Lymphoma, Large B-Cell, Diffuse Recurrence

Other Conditions

Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia

Stopping Reasons

Administratively complete.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID